Review Article

Elevated Urinary Neutrophil Gelatinase-Associated Lipocalin Is a Biomarker for Lupus Nephritis: A Systematic Review and Meta-Analysis

Table 3

Pooled accuracy indices, subgroup analysis, and sensitivity analysis of uNGAL.

Number of studiesPooled sensitivity (95% CI) (%)Pooled specificity (95% CI) (%)Pooled PLR (95% CI)Pooled NLR (95% CI)Pooled DOR (95% CI)AUC

Part 1: the diagnostic accuracy for uNGAL to identify LN
All (9)0.84 (0.71, 0.91)86.200.91 (0.70, 0.98)88.939.08 (2.31, 35.69)0.18 (0.09, 0.35)50.51 (8.15, 313.03)0.92
subgroup (4)081 (0.81, 0.91)89.900.95 (0.89, 0.98)62.7010.75 (2.65, 43.57)0.21 (0.07, 0.67)60.96 (6.09, 610.22)1.00
Part 2: the diagnostic accuracy for uNGAL to identify active LN
All (10)0.72 (0.56, 0.84)91.170.71 (0.51, 0.84)94.242.45 (1.32, 4.54)0.39 (0.22, 0.70)6.24 (2.08, 18.68)0.77
Cross-sectional subgroup (4)0.87 (0.71, 0.95)84.560.82 (0.57, 0.94)84.044.89 (1.63, 14.67)0.16 (0.06, 0.43)30.60 (4.30, 217.68)0.92
Prospective cohort subgroup (6)0.57 (0.37, 0.75)89.830.61 (0.40, 0.79)94.921.46 (1.12, 1.91)0.71 (0.56, 0.88)2.07 (1.39, 3.08)0.62
Part 3: the diagnostic accuracy for uNGAL to predict renal flare
All (6)0.80 (0.57, 0.92)72.500.67 (0.58, 0.75)66.152.41 (1.57, 3.72)0.30 (0.11, 0.79)8.08 (2.02, 32.35)0.74
R-SLEDAI subgroup (3)0.90 (0.80, 0.96)55.400.74 (0.66, 0.81)21.703.41 (2.31, 5.03)0.17 (0.07, 0.40)20.75 (6.13, 70.29)
Five studies without Elewa 20150.73 (0.54, 0.86)65.050.63 (0.56, 0.70)43.961.97 (1.41, 2.77)0.43 (0.23, 0.82)4.55 (1.74, 11.87)0.68
Part 4: the diagnostic accuracy for uNGAL to identify proliferative LN
All (2)0.87 (0.66, 0.97)0.69 (0.39, 0.91)2.89 (1.26, 6.61)0.20 (0.06, 0.65)16.42 (2.56, 105.37)

CI: confidence interval; PLR: positive likelihood ratio; NLR: negative likelihood ratio; DOR: diagnostic odds ratio; AUC: area under the curve. CS: cross-sectional study; PC: prospective cohort study. QUADAS-2: quality assessment tool for diagnostic accuracy studies 2; R-SLEDAI: renal Systemic Lupus Erythematosus Disease Activity Index.